Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen.

B S Prabhakar; G P Allaway; J Srinivasappa; A L Notkins

doi:10.1172/JCI114838

Laboratory of Oral Medicine, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Prabhakar, B. in: PubMed | Google Scholar

Laboratory of Oral Medicine, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Allaway, G. in: PubMed | Google Scholar

Laboratory of Oral Medicine, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Srinivasappa, J. in: PubMed | Google Scholar

Laboratory of Oral Medicine, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.

Find articles by Notkins, A. in: PubMed | Google Scholar

Published in Volume 86, Issue 4 on October 1, 1990
J Clin Invest. 1990;86(4):1301–1305. https://doi.org/10.1172/JCI114838.
© 1990 The American Society for Clinical Investigation

Published October 1, 1990 - Version history

The Ku complex, a heterodimer of 86- and 70-kD proteins, is a nuclear DNA-binding autoantigen. However, hydrophobicity analysis of the deduced amino acid sequence of the 70-kD protein had strongly suggested that this might also be a membrane protein. In the present study, using antibodies to synthetic peptides and a polyclonal antiserum to the purified protein, we show that the 70-kD protein of the Ku complex is present in isolated plasma membranes of human cells. By indirect immunofluorescence microscopy and fluorescein-activated cell sorting, we demonstrate that this autoantigen is exposed on the cell surface. In addition, we have identified several domains of the protein that are exposed. Our study provides one of the first demonstrations of a eukaryotic, nuclear DNA-binding protein that is also on the cell membrane. Moreover, our results might help explain how autoantibodies to the Ku autoantigen could target cells for an autoimmune attack.

Images.